Evaluation of tobacco control policies
Our unit evaluates the impact of tobacco control interventions in England and internationally. This work has included evaluations of key tobacco control policies in England using routine data sources.
This includes assessing the impact of:
- legislation eliminating smoking from public places on tobacco use and important child health outcomes, including prematurity, low birth weight and hospital admissions for asthma
- legislation increasing the legal age for the purchase for tobacco from 16 to 18 years
- removing tobacco imagery from youth-rated movies
- providing financial incentives to doctors to offer cessation advice to patients in primary care
International work includes modelling the impact of tobacco control interventions on smoking prevalence and cardiovascular disease mortality in India and China.
Our unit also studies the epidemiology and legislative components of non-cigarette tobacco products, namely waterpipe tobacco smoking. This includes assessing prevalence and trends using routine data sources and evaluating tobacco control and primary care cessation interventions. We are part of the Cochrane Tobacco Addictions Group.
Quantifying the impact of tobacco control interventions on health outcomes in middle-income countries, assessing the impact of introducing smoke-free public places on child health and inequalities in health outcomes.
Country focus: England, India, China, Brazil
International work includes modelling the impact of tobacco control interventions on smoking prevalence and assessment of the relative benefits of tobacco control compared to pharmacological CVD therapies. The unit has received funding from the World Health Organization (China country office) to examine the impact of different tobacco control policies in China.